Autosomal recessive hypertrophic cardiomyopathy associated with variants in TRIM63

<h2>Abstract</h2><h3>Background</h3> Hypertrophic cardiomyopathy (HCM) is typically linked to dominant variants in sarcomeric genes, but rare minor genes, including <i>TRIM63</i> coding for an E3 ubiquitin-protein ligase, have recently emerged as potential causes of recessive HCM. <h3>Methods and results</h3> Among 517 adult patients with clinical HCM who underwent next-generation sequencing, we found six index cases carrying biallelic <i>TRIM63</i> variants—four homozygous and two compound heterozygous. They presented with early-onset disease, marked concentric hypertrophy, diffuse myocardial fibrosis, and progressive left ventricular dysfunction. One patient underwent heart transplantation. No cardiac disease was found in heterozygous relatives. <h3>Conclusions</h3> <i>TRIM63</i>-related HCM is rare but clinically distinct. Early identification of <i>TRIM63</i> homozygous and two compound heterozygous variants in HCM is crucial and warrants proactive clinical surveillance. <b>Take home messages:</b><ul><li>•TRIM63-related HCM is a rare autosomal-recessive subtype with early onset and severe phenotypes.</li><li>•Rapid disease progression is common, with extensive fibrosis and frequent transition to hypokinetic-dilated end-stage cardiomyopathy.</li><li>•Early genetic diagnosis supports proactive management, including timely ICD implantation for arrhythmia risk and reproductive counselling for families due to the recessive inheritance.</li></ul>

Authors

Institutions

Publication Details

Journal
International Journal of Cardiology
Published
2025-11-05
DOI
https://doi.org/10.1016/j.ijcard.2025.134010
Citations
1
Primary Topic
Cardiomyopathy and Myosin Studies
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Autosomal recessive hypertrophic cardiomyopathy associated with variants in TRIM63

Natascia Cerrato, Fernando Bonanni, Francesca Girolami, Mattia Zampieri et al.
1 citations
International Journal of Cardiology
Cardiomyopathy and Myosin Studies
1.39
article

Autosomal recessive hypertrophic cardiomyopathy associated with variants in TRIM63

Natascia Cerrato, Fernando Bonanni, Francesca Girolami, Mattia Zampieri, V. Barletta, Silvia Passantino, Alessia Gozzini, Alberto Marchi, Giulia Forzano, Maurizio Cecconi, Laura Dosa, A. Ballerini, ED Palinkas, Olivotto
article en
1 citations

Abstract

<h2>Abstract</h2><h3>Background</h3> Hypertrophic cardiomyopathy (HCM) is typically linked to dominant variants in sarcomeric genes, but rare minor genes, including <i>TRIM63</i> coding for an E3 ubiquitin-protein ligase, have recently emerged as potential causes of recessive HCM. <h3>Methods and results</h3> Among 517 adult patients with clinical HCM who underwent next-generation sequencing, we found six index cases carrying biallelic <i>TRIM63</i> variants—four homozygous and two compound heterozygous. They presented with early-onset disease, marked concentric hypertrophy, diffuse myocardial fibrosis, and progressive left ventricular dysfunction. One patient underwent heart transplantation. No cardiac disease was found in heterozygous relatives. <h3>Conclusions</h3> <i>TRIM63</i>-related HCM is rare but clinically distinct. Early identification of <i>TRIM63</i> homozygous and two compound heterozygous variants in HCM is crucial and warrants proactive clinical surveillance. <b>Take home messages:</b><ul><li>•TRIM63-related HCM is a rare autosomal-recessive subtype with early onset and severe phenotypes.</li><li>•Rapid disease progression is common, with extensive fibrosis and frequent transition to hypokinetic-dilated end-stage cardiomyopathy.</li><li>•Early genetic diagnosis supports proactive management, including timely ICD implantation for arrhythmia risk and reproductive counselling for families due to the recessive inheritance.</li></ul>

International Journal of CardiologyVol. 444
Scuola Superiore Sant'Anna (IT), University of Szeged (HU), Istituto Giannina Gaslini (IT), Azienda Sanitaria Locale di Asti (IT), Meyer Children's Hospital (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Azienda Usl Toscana Centro (IT)
Bristol-Myers Squibb, Sanofi, Boston Scientific Corporation, Cytokinetics, Amicus Therapeutics, European Commission, Sanofi Genzyme, HORIZON EUROPE Framework Programme
Openalex Percentile: Top 13%
Cardiomyopathy and Myosin Studies
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.